Insider sale
DYNE THERAPEUTICS, INC.
$3.52M
153.97K shares
What this filing means
ATLAS VENTURE FUND XI, L.P. plans to sell 153.97K shares of DYNE THERAPEUTICS, INC. valued at approximately $3.52M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/7/2026ACC: 0001628280-26-047533
10% Owner
Since Sep 2020
153.97K
Shares to sell
$3.52M
Approx. market value
153.97K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
7/31/2020
153.97KTotal acquired153.97K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/31/2020 | Private Placement Cash | 153.97K | — |
| Total | 153.97K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
153.97K
Market value
$3.52M
7/7/2026
Total
Units
153.97K
Value
$3.52M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/7/2026 | 153.97K | $3.52M | Nasdaq | Planned |
| Total | 153.97K | $3.52M | ||